ASCO Group Meetings

Join Us At ASCO 2026

May 30 to June 1, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ASCO 2026 updates.

Saturday, May 30

9:00 AM CT (10:00 AM ET) - Marc Braunstein

Multiple Myeloma, ET, MF, SM | Attending Physician in Hematology, NYU Winthrop Hospital

9:00 AM CT (10:00 AM ET) - Sanjay Aneja

Prostate | Director of Genitourinary Oncology, Griffin Hospital Inc.

10:00 AM CT (11:00 AM ET) - Komal Jhaveri

Breast Cancer | Clinical Director of the Early Drug Development, Memorial Sloan Kettering Cancer Center

10:00 AM CT (11:00 AM ET) - Gary Steinberg

Bladder Cancer | Professor of Urology, Rush University Medical Center

11:00 AM CT (12:00 PM ET) - Benjamin Besse

Lung | Professor, University of Paris-Saclay

11:00 AM CT (12:00 PM ET) - Ravi Vij

Multiple Myeloma | Professor of Medicine, Washington University in St. Louis

12:00 PM CT (1:00 PM ET) - Thomas Marron

Lung | Associate Director for Translational Research, Tisch Comprehensive Cancer Center, Mount Sinai Health System Inc.

12:00 PM CT (1:00 PM ET) - Paul DiSilvestro

Ovarian/GYN | Professor of Obstetrics and Gynecology, Brown University

1:00 PM CT (2:00 PM ET) - Robert Dreicer

Prostate Cancer | Director of Solid Tumor Oncology Within the Division of Hematology/Oncology and Professor of Medicine and Urology, University of Virginia School of Medicine

1:00 PM CT (2:00 PM ET) - Kamel Abou Hussein

Breast Cancer | Director of Breast Cancer Clinical Trials MD Anderson, Cooper at MD Anderson Cancer Center At Cooper

2:00 PM CT (3:00 PM ET) - Michael Morse

PDAC/CRC | Medical Oncologist, Duke University Health System Inc.

2:00 PM CT (3:00 PM ET) - Ashwin Kishtagari

MPN (MF, PV, ET), AML/MDS | Assistant Professor of Medicine, Vanderbilt University Medical Center

3:00 PM CT (4:00 PM ET) - Benjamin Herzberg

Early Clinical/Lung Cancer | Medical Oncologist and Assistant Professor of Medicine, Columbia University Medical Center

3:00 PM CT (4:00 PM ET) - Cesar Perez

Head and Neck Cancer | Director of Drug Development, Florida Cancer Specialists & Research Institute LLC

4:00 PM CT (5:00 PM ET) - Eric Christenson

PDAC/CRC | Assistant Professor of Oncology, Johns Hopkins University

4:00 PM CT (5:00 PM ET) - Siamak Daneshmand

Bladder Cancer | Associate Professor of Urology (Clinical Scholar); Director of Clinical Research, University of Southern California

Sunday, May 31

9:00 AM CT (10:00 AM ET) - Rodabe Amaria

Melanoma: Emerging IO and targeted therapies | Associate Professor, Department of Melanoma Oncology, University of Texas M. D. Anderson Cancer Center

9:00 AM CT (10:00 AM ET) - Timothy Yap

Early Clinical | Head of Clinical Development in the Therapeutics Discovery Division, University of Texas M. D. Anderson Cancer Center

10:00 AM CT (11:00 AM ET) - Benjamin Gartrell

Prostate Cancer | Associate Professor of Oncology in Medical Oncology, Associate Professor of Medicine in Oncology and Hematology, and Associate Professor of Urology, Albert Einstein College of Medicine

10:00 AM CT (11:00 AM ET) - Patrick Forde

Lung Cancer | Prendergast Professor and Chair of Immuno-Oncology, Trinity College Dublin, The University of Dublin

11:00 AM CT (12:00 PM ET) - Premal Thaker

Ovarian/GYN | Associate Professor in Gynecologic Oncology and Director of Gynecological Oncology Clinical Research, Washington University, St. Louis

11:00 AM CT (12:00 PM ET) - Giancarlo Moscol

Breast Cancer | Associate Professor of Breast Medical Oncology in Cancer Medicine, University of Texas M. D. Anderson Cancer Center

12:00 PM CT (1:00 PM ET) - Jerome Fayette

Head and Neck Cancer | Medical Oncologist, Centre Léon Bérard

12:00 PM CT (1:00 PM ET) - Elias Jabbour

AML/MDS, CML, ALL | Associate Professor, University of Texas M. D. Anderson Cancer Center

1:00 PM CT (2:00 PM ET) - David Camidge

Lung Cancer | Professor of Medical Oncology and the Director of Thoracic Oncology and the Thoracic Oncology Clinical Research Program, University of Colorado

1:00 PM CT (2:00 PM ET) - Seth Wander

Breast Cancer | Clinical Assistant in Medicine / Medical Oncologist at Massachusetts General Hospital, Harvard Medical School

2:00 PM CT (3:00 PM ET) - Aarti Bhatia

Head and Neck Cancer | Clinical Research Team Leader for the Head and Neck Cancers Program and an Associate Professor of Medical Oncology, Yale University School Of Medicine

2:00 PM CT (3:00 PM ET) - Scott Tagawa

Prostate Cancer | Attending Physician, The New York and Presbyterian Hospital Inc.

3:00 PM CT (4:00 PM ET) - Daniel Olson

Melanoma: Emerging IO and targeted therapies | Assistant Professor of Medicine, The University of Chicago

3:00 PM CT (4:00 PM ET) - Joshua Brody

Lymphomas | Associate Professor, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai

4:00 PM CT (5:00 PM ET) - Michael Pishvaian

PDAC/CRC | Director of the Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs, Johns Hopkins School of Medicine

4:00 PM CT (5:00 PM ET) - Rajwanth Veluswamy

Lung Cancer | Associate Professor of Medicine, NYU Langone Hospitals

Monday, June 1

8:00 AM CT (9:00 AM ET) - Jordi Rodón

PRMT5 | Associate Medical Director at the Institute for Personalized Cancer Therapy and the Clinical Co-Director of the Precision Oncology Decision Support Group in the Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center

8:00 AM CT (9:00 AM ET) - Peter Enzinger

PDAC/CRC | Medical Oncologist and Director of the Center for Esophageal and Gastric Cancer, Harvard Medical School

9:00 AM CT (10:00 AM ET) - Christos Vaklavas

Breast Cancer | Professor of Medicine in the Division of Oncology and Physician Lead in Breast Cancer, University of Utah

9:00 AM CT (10:00 AM ET) - Roy Herbst

Lung Cancer | Chief of Medical Oncology, Yale University School Of Medicine

10:00 AM CT (11:00 AM ET) - Jason Luke

Melanoma: Emerging IO and targeted therapies | CMO, Strand Therapeutics Inc.

10:00 AM CT (11:00 AM ET) - David Hong

PDAC/KRAS | Deputy Director of the Department of Investigational Cancer Therapeutics in the Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center

11:00 AM CT (12:00 PM ET) - Jason Henry

Early Clinical | Associate Director of Drug Development, Sarah Cannon Research Institute LLC

11:00 AM CT (12:00 PM ET) - Jared Weiss

Lung Cancer | Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology, University of North Carolina, Chapel Hill School of Medicine

12:00 PM CT (1:00 PM ET) - Kevin Kalinsky

Breast Cancer | Director, Director of the Glenn Family Breast Center at the Winship Cancer Institute of Emory University, Emory University School of Medicine

12:00 PM CT (1:00 PM ET) - Ignacio Garrido-Laguna

PDAC: KRAS | Chair of Experimental Therapeutics, H. Lee Moffitt Cancer Center & Research Institute Inc.

1:00 PM CT (2:00 PM ET) - Ryan Corcoran

PDAC/CRC | GI Oncologist and Director of the Tucker Gosnell Center for Gastrointestinal Cancers, Alterome Therapeutics Inc.

1:00 PM CT (2:00 PM ET) - John Mascarenhas

MPN (MF, PV, ET), AML | Professor of Medicine, Icahn School of Medicine at Mount Sinai

2:00 PM CT (3:00 PM ET) - Namrata Vijayvergia

PDAC/CRC | Section Chief in the Division of Gastrointestinal Oncology, Fox Chase Cancer Center Medical Group Inc.

2:00 PM CT (3:00 PM ET) - Konstantin Dragnev

Lung Cancer | Interim Director, Dartmouth Cancer Center

3:00 PM CT (4:00 PM ET) - Nataliya Uboha

PDAC/CRC | Associate Professor of Medicine and the Faculty Leader of the Early-Phase Oncology Therapeutics Program, University of Wisconsin - Madison

3:00 PM CT (4:00 PM ET) - Praveen Vikas

Breast Cancer | Clinical Associate Professor, Medical Oncologist, University of Iowa Hospitals and Clinics

*ASCO Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.